Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | |
| Cash Flows From Operating Activities | |
| Net Income | 12,819 |
| Depreciation Amortization | 11,228 |
| Income taxes - deferred | -555 |
| Other Working Capital | -11,046 |
| Loans | -1,228 |
| Other Operating Activity | 2,428 |
| Operating Cash Flow | $13,646 |
| Cash Flows From Investing Activities | |
| PPE Investments | -5,119 |
| Purchase Of Investment | -98,954 |
| Sale Of Investment | 159,875 |
| Net Loans | -311,447 |
| Other Investing Activity | 10,782 |
| Investing Cash Flow | $-244,863 |
| Cash Flows From Financing Activities | |
| Change In Short Term Borrowing | 19,441 |
| Debt Issued | 330,877 |
| Debt Repayment | -160,123 |
| Common Stock Issued | 144 |
| Other Financing Activity | -23,810 |
| Financing Cash Flow | $238,472 |
| Beginning Cash Position | 88,331 |
| End Cash Position | 95,586 |
| Net Cash Flow | $7,255 |
| Free Cash Flow | |
| Operating Cash Flow | 13,646 |
| Capital Expenditure | -5,119 |
| Free Cash Flow | 8,527 |